XML 36 R5.htm IDEA: XBRL DOCUMENT v3.25.2
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenue $ 1,271 $ 1,345
Cost of revenue (652) (612)
Gross profit 619 733
Selling, general and administrative expenses (4,410) (6,758)
Research and development expenses (3,655) (3,773)
Operating loss (7,446) (9,798)
Impairment loss on PPE 0 (3,345)
Other income, net 325 143
Loss before income taxes (7,121) (13,000)
Income tax expense/benefit 0 0
Net loss attributable to common stockholders (7,121) (13,000)
Foreign currency translation adjustments (30) (34)
Comprehensive loss $ (7,151) $ (13,034)
Net loss per share attributable to common stockholders:    
Basic and diluted (in Dollars per share) $ (0.09) $ (0.22)
Basic and diluted (in Dollars per share) $ (0.09) $ (0.22)
Weighted-average number of shares used in computing loss per share amounts: (in Shares) 76,517,175 58,839,868
Weighted-average number of shares used in computing loss per share amounts: (in Shares) 76,517,175 58,839,868